IQVIA Holdings stock rises 1.23% and outperforms peers

11 articles · Updated · MarketWatch · May 7

Shares closed at $178.64 on Thursday, extending gains to a fourth straight session as the S&P 500 fell 0.38% and the Dow dropped 0.63%.
IQVIA beat healthcare peers including HCA Healthcare and Centene, which both declined, while Labcorp posted a smaller 0.43% rise.
The stock remains 27.69% below its 52-week high of $247.05 reached on 9 January, while trading volume of 1.8 million matched its 50-day average.

Can IQVIA’s AI strategy outpace industry-wide talent shortages and pricing pressures to secure its promised growth?

As IQVIA's AI consumes vast patient data, how will it navigate tightening global regulations on data privacy?